Cite
HARVARD Citation
Delaunois, A. et al. (2023). Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study. Pharmacology research & perspectives. 11 (1), p. n/a. [Online].